Skip to content
Screener

Prestige Consumer Healthcare PBH Eye & Ear Care — Total revenues

Other product segments

Gastrointestinal
$62.2M+7.6%
Women's Health
$52.54M-3.7%
Dermatologicals
$33.2M+10.2%
Pain Relief
$26.8M—
Oral Care
$22.36M+3.0%
Cough, Cold & Allergy
$21.31M—
Wellness, Sleep & Other
$14.33M—

Similar metrics at other companies

Mirion Technologies logo
MIRCancer care — Total revenues
$62.8M+1.0%
ALN
ALNYTotal Rare — Total revenues
$141.89M+11.1%
TBR
TBRGPatient Care — Total revenues
$33M+6.2%
Bausch + Lomb logo
BLCOVision Care — Total revenues
$784M+4.1%
Red Robin Gourmet Burgers logo
RRGBGift card breakage — Total revenues
$1.88M+10.1%
PK
PKCore Hotels — Total revenues
$560M+6.7%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)Three Months Ended June 30, 2026 / North American OTCHealthcareThree Months Ended June 30, 2026 / International OTCHealthcareConsolidated
Cough, Cold & Allergy$15,628$5,677$21,305
Dermatologicals30,6152,58033,195
Eye & Ear Care28,3394,63932,978
Gastrointestinal47,14115,06162,202
Oral Care18,4583,90022,358
Pain Relief26,22557726,802
Wellness, Sleep & Other12,5591,76814,327
Women's Health47,2415,30252,543

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's eye & ear care — total revenues?
Prestige Consumer Healthcare (PBH) reported eye & ear care — total revenues of $32.98M in Q2 2026.
How has Prestige Consumer Healthcare's eye & ear care — total revenues changed year-over-year?
Prestige Consumer Healthcare's eye & ear care — total revenues increased by 2.1% year-over-year, from $32.31M to $32.98M.
What is the long-term trend for Prestige Consumer Healthcare's eye & ear care — total revenues?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's eye & ear care — total revenues has grown at a -3.3% compound annual growth rate (CAGR), from $163.45M to $142.94M.
What does eye & ear care — total revenues mean?
This metric represents the total gross revenue generated from the sale of eye and ear care products within the company's consumer healthcare portfolio. It reflects the market demand and commercial performance of brands focused on ocular and auditory health, such as redness relief solutions. Monitoring this figure helps investors assess the growth trajectory and competitive positioning of the company's specialized healthcare offerings.

Ask your AI about Prestige Consumer Healthcare's eye & ear care — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude